Azafaros
0 followers
Azafaros is developing new treatment options to help patients with rare metabolic disorders. Azafaros was founded in 2018 by a team of experienced industry professionals and scientists aspiring to address rare genetic metabolic disorders through a pipeline of oral small molecules with disease-modify... Read more
Org chart
Stefano Portolano
Chief Executive Officer
Stefano Portolano
Collapse
Silvia Ragno
Chief Operating Officer
Christian Freitag
Chief Medical Officer
Anke Arnold-Tugulu
Head of Regulatory Affairs
Laura López de Frutos
Regional Medical Director Europe
Dr. Kyung-Jae Na
Head of CMC
Henrik Torp Nielsen
Senior International Finance & Business Leader
Board & advisors
Carlo Incerti
Chairman & Non-Executive Board Member
Edward Van Wezel
Executive Board Member
Vanessa King
Non-Executive Board Member
Sander Slootweg
Non-Executive Board Member
Kiran Dallenbach
Board Member